Barton F. Haynes

77.2k citations

432 papers · 34.7k indexed · 14 hit papers · h-index 90

Virology top 0.01%
- HIV Research and Treatment 230
Immunology top 0.02%
- Immune Cell Function and Interaction 174
- T-cell and B-cell Immunology 117
- Immunotherapy and Immune Responses 48
Infectious Diseases top 0.05%
- HIV/AIDS drug development and treatment 35
Radiology, Nuclear Medicine and Imaging top 0.1%
- Monoclonal and Polyclonal Antibodies Research 77
Immunology and Allergy top 0.5%
Molecular Biology
- vaccines and immunoinformatics approaches 55
- Glycosylation and Glycoproteins Research 34

Co-authors: Anthony S. Fauci Hua‐Xin Liao Sheldon Wolff Laura P. Hale Paul Katz Georgia D. Tomaras T J Palker Andrew J. McMichael
Cited by: Virology Immunology Infectious Diseases
Partner nations: United States United Kingdom South Korea

In The Last Decade

Barton F. Haynes

424 papers receiving 33.2k citations

Hit Papers

14 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2022 Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
2021 Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
2021 SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
2021 Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity
2012 Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
2011 Acute HIV-1 Infection
2009 The immune response during acute HIV-1 infection: clues for vaccine development
2005 Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies
2002 Diversity Considerations in HIV-1 Vaccine Selection
1998 Changes in thymic function with age and during the treatment of HIV infection
1996 A Pathogenetic Role for TNFα in the Syndrome of Cachexia, Arthritis, and Autoimmunity Resulting from Tristetraprolin (TTP) Deficiency
1988 Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.
1984 Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS
1983 Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 Years

Peers

Countries citing papers authored by Barton F. Haynes

Since Specialization

Citations

This map shows the geographic impact of Barton F. Haynes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barton F. Haynes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barton F. Haynes more than expected).

Fields of papers citing papers by Barton F. Haynes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barton F. Haynes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barton F. Haynes. The network helps show where Barton F. Haynes may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Barton F. Haynes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barton F. Haynes Line = papers co-authored together Barton F. Haynes links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	SARS-CoV-2 Omicron XBB lineage spike structures, conformations, antigenicity, and receptor recognition Qianyi E Zhang,Jared Lindenberger,Ruth Parsons,Bhishem Thakur,Rob Parks,Chan Soo Park,Xiao Huang,Salam Sammour,Katarzyna Janowska,Taylor N. Spence,Robert J. Edwards,Mitchell Martin,Wilton B. Williams,S. Gobeil,David C. Montefiori,Bette Korber,Kevin O. Saunders,Barton F. Haynes,Rory Henderson,Priyamvada Acharya	2024	10
2	Author Correction: Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies Barton F. Haynes,Kevin Wiehe,Persephone Borrow,Kevin O. Saunders,Bette Korber,Kshitij Wagh,Andrew J. McMichael,Garnett Kelsoe,Beatrice H. Hahn,Frederick W. Alt,George M. Shaw	2023	6
3	Structural basis for breadth development in the HIV-1 V3-glycan targeting DH270 antibody clonal lineage Rory Henderson,Ye Zhou,Victoria Stalls,Kevin Wiehe,Kevin O. Saunders,Kshitij Wagh,Kara Anasti,Maggie Barr,Robert Parks,S. Munir Alam,Bette Korber,Barton F. Haynes,Alberto Bartesaghi,Priyamvada Acharya	2023	7
4	Humanized V(D)J-rearranging and TdT-expressing mouse vaccine models with physiological HIV-1 broadly neutralizing antibody precursors Sai Luo,Changbin Jing,Adam Yongxin Ye,Sven Kratochvil,Christopher A. Cottrell,Jahyun Koo,Aimee Williams,Lucas Vieira Francisco,Himanshu Batra,Edward Lamperti,Oleksandr Kalyuzhniy,Yuxiang Zhang,Alessandro Barbieri,John Manis,Barton F. Haynes,William R. Schief,Facundo D. Batista,Ming Tian,Frederick W. Alt	2022	11
5	Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in micebreakdown → David R. Martinez,Alexandra Schäfer,Sarah R. Leist,Gabriela De la Cruz,Ande West,Elena N. Atochina‐Vasserman,Lisa C. Lindesmith,Norbert Pardi,Robert Parks,Maggie Barr,Dapeng Li,Boyd L. Yount,Kevin O. Saunders,Drew Weissman,Barton F. Haynes,Stephanie A. Montgomery,Ralph S. Baric	2021	93
6	Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicitybreakdown → S. Gobeil,Katarzyna Janowska,Shana McDowell,Katayoun Mansouri,Robert Parks,Victoria Stalls,Megan Kopp,Kartik Manne,Dapeng Li,Kevin Wiehe,Kevin O. Saunders,Robert J. Edwards,Bette Korber,Barton F. Haynes,Rory Henderson,Priyamvada Acharya	2021	247
7	Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth Krishna M. Roskin,Katherine Jackson,Ji-Yeun Lee,Ramona A. Hoh,Shilpa A. Joshi,Kwan‐Ki Hwang,Mattia Bonsignori,Isabela Pedroza‐Pacheco,Hua‐Xin Liao,M. Anthony Moody,Andrew Fire,Persephone Borrow,Barton F. Haynes,Scott D. Boyd	2020	37
8	Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques Maria Blasi,Elizabeth C. Wescott,Erich J. Baker,Benjamin Mildenberg,Celia C. LaBranche,Wes Rountree,Barton F. Haynes,Kevin O. Saunders,M. Anthony Moody,Donatella Negri,Sampa Santra,Andrea Cara,Mary E. Klotman	2020	14
9	Cross-Reactivity to Kynureninase Tolerizes B Cells That Express the HIV-1 Broadly Neutralizing Antibody 2F5 Joel Finney,Guang Yang,Masayuki Kuraoka,Shengli Song,Takuya Nojima,Laurent Verkoczy,Daisuke Kitamura,Barton F. Haynes,Garnett Kelsoe	2019	8
10	Glycoengineering HIV-1 Env creates ‘supercharged’ and ‘hybrid’ glycans to increase neutralizing antibody potency, breadth and saturation Ema T. Crooks,Samantha L. Grimley,Michelle D. Cully,Keiko Osawa,Gillian Dekkers,Kevin O. Saunders,Sebastian Rämisch,Sergey Menis,William R. Schief,Nicole A. Doria‐Rose,Barton F. Haynes,Ben Murrell,Evan M. Cale,Amarendra Pegu,John R. Mascola,Gestur Vidarsson,James Μ. Binley	2018	19
11	Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses Matthew Zirui Tay,Pinghuang Liu,LaTonya D. Williams,Michael D. McRaven,Sheetal Sawant,Thaddeus C. Gurley,Thomas T. Xu,S. Moses Dennison,Hua-Xin Liao,Agnès‐Laurence Chenine,S. Munir Alam,M. Anthony Moody,Thomas J. Hope,Barton F. Haynes,Georgia D. Tomaras	2016	79
12	Capacity for Infectious HIV-1 Virion Capture Differs by Envelope Antibody Specificity Pinghuang Liu,LaTonya D. Williams,Xiaoying Shen,Mattia Bonsignori,Nathan Vandergrift,R. Glenn Overman,M. Anthony Moody,Hua-Xin Liao,Daniel J Stieh,Kerrie L. McCotter,Audrey L. French,Thomas J. Hope,Robin J. Shattock,Barton F. Haynes,Georgia D. Tomaras	2014	28
13	Interaction with Cellular CD4 Exposes HIV-1 Envelope Epitopes Targeted by Antibody-Dependent Cell-Mediated Cytotoxicity Maxime Veillette,Anik Désormeaux,Halima Medjahed,Nour-Elhouda Gharsallah,Mathieu Coutu,Joshua Baalwa,Yongjun Guan,George K. Lewis,Guido Ferrari,Beatrice H. Hahn,Barton F. Haynes,James E. Robinson,Daniel E. Kaufmann,Mattia Bonsignori,Joseph Sodroski,Andrés Finzi	2013	202
14	Differences in HIV-Specific T Cell Responses between HIV-Exposed and -Unexposed HIV-Seronegative Individuals Adam Ritchie,Suzanne Campion,Jakub Kopycinski,Zoe Moodie,Z. Maggie Wang,K. Pandya,S. S. Moore,Michael K. P. Liu,Simon Brackenridge,Kristin Kuldanek,Kenneth Legg,Myron S. Cohen,Eric Delwart,Barton F. Haynes,Sarah Fidler,Andrew J. McMichael,Nilu Goonetilleke	2011	33
15	Nonneutralizing HIV-1 gp41 Envelope Cluster II Human Monoclonal Antibodies Show Polyreactivity for Binding to Phospholipids and Protein Autoantigens S. Moses Dennison,Kara Anasti,Richard M. Scearce,Laura L. Sutherland,Robert Parks,Shi-Mao Xia,Hua‐Xin Liao,Miroslaw K. Górny,Susan Zolla‐Pazner,Barton F. Haynes,S. Munir Alam	2010	27
16	Low-Dose Mucosal Simian Immunodeficiency Virus Infection Restricts Early Replication Kinetics and Transmitted Virus Variants in Rhesus Monkeys Jinyan Liu,Brandon F. Keele,Hui Li,Sheila M. Keating,Philip J. Norris,Angela Carville,Keith G. Mansfield,Georgia D. Tomaras,Barton F. Haynes,Dror Kolodkin‐Gal,Norman L. Letvin,Beatrice H. Hahn,George M. Shaw,Dan H. Barouch	2010	88
17	Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users Katharine J. Bar,Hui Li,Annie Chamberland,Cécile Tremblay,Jean Pierre Routy,Truman Grayson,Chuanxi Sun,Shuyi Wang,Gerald H. Learn,Charity J. Morgan,Joseph E. Schumacher,Barton F. Haynes,Brandon F. Keele,Beatrice H. Hahn,George M. Shaw	2010	150
18	Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance Laurent Verkoczy,Marilyn Diaz,T. Matt Holl,Ying-Bin Ouyang,Hilary Bouton-Verville,S. Munir Alam,Hua‐Xin Liao,Garnett Kelsoe,Barton F. Haynes	2009	131
19	Expanded Breadth of the T-Cell Response to Mosaic Human Immunodeficiency Virus Type 1 Envelope DNA Vaccination Wing-Pui Kong,Lan Wu,Timothy C. Wallstrom,Will Fischer,Zhi-Yong Yang,Sung‐Youl Ko,Norman L. Letvin,Barton F. Haynes,Beatrice H. Hahn,Bette Korber,Gary J. Nabel	2008	54
20	Murine CD7 Shares Antigenic Cross-Reactivity with HSP-60 Brandon A. Howard,Gregory D. Sempowski,Richard M. Scearce,Hua‐Xin Liao,David Lee,Gordon K. Lam,Haiyen Chen,Patrick Fadden,Timothy Haystead,Barton F. Haynes	2008	1

About Barton F. Haynes

Barton F. Haynes is a scholar working on Virology, Immunology and Infectious Diseases, having authored 432 papers that have together received 34.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (230 papers), Immune Cell Function and Interaction (174 papers), T-cell and B-cell Immunology (117 papers), Monoclonal and Polyclonal Antibodies Research (77 papers), vaccines and immunoinformatics approaches (55 papers), Immunotherapy and Immune Responses (48 papers), HIV/AIDS drug development and treatment (35 papers) and Glycosylation and Glycoproteins Research (34 papers). The work is most often cited by research in Virology (14.9k citations), Immunology (16.7k citations) and Infectious Diseases (8.5k citations). Barton F. Haynes has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Anthony S. Fauci, Hua‐Xin Liao, Sheldon Wolff, Laura P. Hale, Paul Katz, Georgia D. Tomaras, T J Palker, Andrew J. McMichael, S. Munir Alam and David C. Montefiori.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact